Critical Survey: ASP Isotopes (NASDAQ:ASPI) & Basf (OTCMKTS:BASFY)

Basf (OTCMKTS:BASFY) and ASP Isotopes (NASDAQ:ASPI) are both basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, profitability, risk and earnings.

Analyst Ratings

This is a summary of recent ratings and target prices for Basf and ASP Isotopes, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Basf	2	1	5	0	2.38
ASP Isotopes	1	0	1	0	2.00

ASP Isotopes has a consensus price target of $13.00, indicating a potential upside of 28.21%. Given ASP Isotopes’ higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Basf.

Insider & Institutional Ownership

0.0% of Basf shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 21.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Profitability

This table compares Basf and ASP Isotopes’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Basf	0.43%	6.88%	3.09%
ASP Isotopes	-2,181.62%	-239.22%	-98.70%

Volatility and Risk

Basf has a beta of 1.07, suggesting that its share price is 7% more volatile than the S&P 500. Comparatively, ASP Isotopes has a beta of 3.28, suggesting that its share price is 228% more volatile than the S&P 500.

Valuation & Earnings

This table compares Basf and ASP Isotopes”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Basf	$70.63 billion	0.62	$1.40 billion	$0.10	122.80
ASP Isotopes	$4.14 million	228.79	-$32.33 million	($1.27)	-7.98

Basf has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Basf, indicating that it is currently the more affordable of the two stocks.

Summary

Basf beats ASP Isotopes on 9 of the 14 factors compared between the two stocks.

About Basf

BASF SE operates as a chemical company worldwide. It operates through six segments: Chemicals, Materials, Industrial Solutions, Surface Technologies, Nutrition & Care, and Agricultural Solutions. The Chemicals segment provides petrochemicals and intermediates. The Materials segment offers advanced materials and their precursors for applications and systems comprising isocyanates, polyamides, and inorganic basic products, as well as specialties for plastics and plastics processing industries. The Industrial Solutions segment develops and markets ingredients and additives for industrial applications, such as polymer dispersions, resins, additives, electronic materials, and antioxidants for automotive, plastics, paints and coatings, electronics, and energy and resource industries. The Surface Technologies segment provides automotive OEM and refinish coatings, surface treatment, catalysts, battery materials, and precious and base metal services for the automotive and chemical sectors. The Nutrition & Care segment offers ingredients for consumer goods in the areas of nutrition, home, personal care, and technical applications; and serves the food and feed producers, pharmaceutical, cosmetics, detergents, cleaners, and crop protection industries, as well as fast-moving consumer goods sector. The Agricultural Solutions segment provides seeds and seed treatment products; fungicides, herbicides, insecticides, and biological crop protection products; and digital farming solutions. The company engages in engineering and other; rental and leasing; and commodity trading activities. BASF SE was founded in 1865 and is headquartered in Ludwigshafen am Rhein, Germany.

About ASP Isotopes

ASP Isotopes Inc., a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc. was incorporated in 2021 and is headquartered in Washington, District Of Columbia.